Prenatal drug exposure and the conceptualization of long-term effects

Scandinavian Journal of Psychology

Volumn 43, Issue 1, 2002, Pages 41-47

  Moe, Vibeke ^b   Slinning, Kari ^a  

^a Aline Infant and Family Center   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Biological risk; Confounding variables; Prenatal substance exposure; Teratology model; Transactional model

Indexed keywords

ADULT; ARTICLE; CAREGIVER; ENVIRONMENT; FEMALE; FOSTER CARE; HUMAN; MALE; PREGNANCY; PRENATAL EXPOSURE; TIME;

ADULT; CAREGIVERS; ENVIRONMENT; FEMALE; FOSTER HOME CARE; HUMANS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TIME;

EID: 0036484179     PISSN: 00365564     EISSN: None     Source Type: Journal    
DOI: 10.1111/1467-9450.00267     Document Type: Article

References (57)

1. Alessandri, S. M., Bendersky, M. & Lewis, M. (1998). Cognitive functioning in 8 to 18 month old drug exposed infants. Developmental Psychobiology, 34, 565-573
2. Amaro, H., Fried, L., Cabral, H. & Zuckerman, B. (1990). Violence during pregnancy and substance abuse. American Journal of Public Health, 80, 575-579.
3. Azuma, S. D. & Chasnoff, I. J. (1993). Outcome of children prenatally exposed to cocaine and other drugs: A path analysis of three-year data. Pediatrics, 92, 396-402.
4. Barth, R. P. & Needell, B. (1996). Outcomes for drug-exposed children four years post-adoption. Children and Youth Services Review, 18, 37-56.
5. Beckwith, L., Howard, J., Espinosa, M. & Tyler, R. (1999). Psychopathology, mother-child interaction, and infant development: Substance-abusing mothers and their offspring. Development and Psychopathology, 11, 715-725.
6. Beeghly, M. & Tronick, E. Z. (1994). Effects of prenatal exposure to cocaine in early infancy: toxic effects on the process of mutual regulation. Infant Mental Health Journal, 15, 158-175.
7. Bingol, N., Fuchs, M., Diaz, V., Stone, R. K. & Gromisch, D. S. (1987). Teratogenicity of cocaine in humans. Journal of Pediatrics, 110, 93-96.
8. Brooks, C., Zuckerman, B., Bamforth, A., Cole, J. & Kaplan-Sanoff, M. (1994). Clinical issues related to substance-involved mothers and their infants. Infant Mental Health Journal, 15, 202-217.
9. Chasnoff, I. J., Anson, A., Hatcher, R., Stenson, H., Iaukea, K. & Randolph, L. A. (1998). Prenatal exposure to cocaine and other drugs. Outcome at four to six years. Annals of the New York Academy of Sciences, 846, 314-328.
10. Chasnoff, I. J., Burns, K. A., Burns, W. J. & Schnoll, S. H. (1986). Prenatal drug exposure: Effects on neonatal and infant growth and development. Neurobehavioral Toxicology and Teratology, 8, 357-362.
11. Chasnoff, I. J., Burns, W., Schnoll, S. H. & Burns, K. A. (1985). Cocaine use in pregnancy. New England Journal of Medicine, 313, 666-669.
12. Chasnoff, I. J., Griffith, D. R., MacGregor, S., Dirkes, K. & Burns, K. (1989). Temporal patterns of cocaine use in pregnancy. Journal of the American Medical Association, 261, 1741-1744.
13. Cicchetti, D., Ganiban, J. & Barnett, D. (1991). Contributions from the study of high-risk populations to understanding the development of emotion regulation. In J. Garber & K. Dodge (Eds), The development of emotion regulation and dysregulation (pp. 15-48). Cambridge: Cambridge University Press.
14. Cicchetti, D. & Sroufe, A. (2000). Editorial. The past prologue to the future: The times, they've been a-changin'. Development and Psychopathology, 12, 255-264.
15. Coles, C. D., Platzman, K. A., Smith, I., James, M. E. & Falek, A. (1992). Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicology and Teratology, 14, 23-33.
16. Day, N. & Richardson, G. (1991). Prenatal marijuana use: Epidemiology, methodological issues, and infant outcome. Clinics in Perinatology, 18, 77-91.
17. Eyler, F. D., Behnke, M., Conlon, M., Woods, N. S. & Wobie, K. (1998). Birth outcomes from a prospective, matched study of prenatal crack/cocaine use: II. Interactive and dose effects on neurobehavioral assessment. Pediatrics, 101, 237-241.
18. Fetters, L. & Tronick, E. Z. (1996). Neuromotor development of coaine exposed and control infants from birth to 15 months: Poor and poorer performance. Peditrics, 98, 938.
19. Finnegan, L. (1988). Influence of maternal drug dependence of the newborn. In S. Kacew & S. Lock (Eds), Toxicologic and pharmacologic principles in pediatrics (pp. 183-198). New York: Hemisphere.
20. Frank, D. A., Breshnahan, K. & Zuckerman, B. S. (1993). Maternal cocaine use: Impact on child health and development. Advances in Pediatrics, 40, 65-99.
21. Frank, D. A., Zuckerman, B. S., Amaro, H., Aboagye, K., Bauchner, H., Cabral, H., Fried, L., Hingson, R., Kayne, H., Levenson, S. M., Parker, S., Reece, H. & Vinci, R. (1988). Cocaine use during pregnancy: Prevalence and correlates. Pediatrics, 82, 888-895.
22. Franck, E. J. (1996). Prenatally drug-exposed children in out-of-home care: Are we looking at the whole picture? Journal of the Child Welfare League of America, 1, 19-34.
23. Gillogley, K. M., Evans, A. T., Hansen, R. L., Samules, S. J. & Batra, K. K. (1990). The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. American Journal of Obstetrics and Gynecology, 163, 1535-1542.
24. Graham, K. & Koren, G. (1991). Characteristics of pregnant women exposed to cocaine in Toronto between 1985 and 1990. Canadian Medical Association Journal, 144, 563-568.
25. Handler, A., Kistin, N., Davis, F. & Ferré, C. (1991). Cocaine use during pregnancy: Perinatal outcomes. American Journal of Epidemiology, 12, 220-224.
26. Hans, S. L. (1989). Developmental consequences of prenatal exposure to methadone. Annals of the New York Academy Sciences, 562, 195-205.
27. Holzman, C. & Paneth, N. (1994). Maternal cocaine use during pregnancy and perinatal outcomes. Epidemiological Review, 16, 315.
28. Hopkins, W. D. & Bard, K. A. (1993). Hemispheric specialization in infant chimpanzees (Pan troglodytes): Evidence for a relation with gender and arousal. Developmental Psychobiology, 26, 219-235.
29. Jones, K. L. & Smith, D. W. (1973). Recognition of the fetal alcohol syndrome in early infancy. Lancet, 2, 999-1001.
30. Jones, K. L., Smith, D. W., Ulleland, C. N. & Streissguth, A. P. (1973). Pattern of malformation in offspring of chronic alcoholic mothers. Lancet, 1, 267-1271.
31. Koren, G., Nulman, I., Rovet, J., Greenbaum, R., Loebstein, M. & Einarson, T. (1998). Long-term neurodevelopmental risks in children exposed in utero to cocaine. In A. John (Ed.), Cocaine: Effects on the developing brain (pp. 306-313). New York: New York Academy of Sciences.
32. LaGasse, L., Seifer, R. & Lester, B. (1999). Interpreting research on prenatal substance exposure in the context of multiple confounding factors. Clinics in Perinatology, 26, 39-54.
33. Lester, B. (1999). To covary or not to covary: What is the question? Journal of Drug Issues, 29, 263-268.
34. Lester, B.M., LaGasse, L. & Brunner, S. (1997). Database of studies on prenatal cocaine exposure and child outcome. Journal of Drug Issues, 27, 487-499.
35. Lester, B. & Tronick, E. Z. (1994). The effects of prenatal cocaine exposure and child outcome. Infant Mental Health Journal, 15, 107-120.
36. Lester, B. M., Boukydis, Z. C. F. & Twomey, J. E. (2000). Maternal substance abuse and child outcome. In C. H. Zeanah Jr (Ed.), Handbook of infant mental health, 2nd edn. (pp. 161-175). New York: Guilford Press.
37. MacGregor, S. N., Keith, L. G., Chasnoff, I. J., Rosner, M. A., Chisum, G. M., Shaw, P. & Minogue, J. P. (1987). Cocaine use during pregnancy: Adverse perinatal outcome. American Journal of Obstetrics and Gynecology, 157, 686-690.
38. Mayes, L. C. (1994). Neurobiology of prenatal cocaine exposure effect on developing monoamine systems. Infant Mental Health Journal, 15, 121-133.
39. Minde, K. (1993). Prematurity and serious medical illness in infancy: Implications for development and intervention. In C. H. Zeanah, Jr (Ed.), Handbook of infant mental health (pp. 87-105). New York: Guilford Press.
40. Moe, V. & Slinning, K. (2001). Children prenatally exposed to substances: Gender-related differences in outcome from infancy to 3 years of age. Infant Mental Health Journal, 3, 334-350.
41. Morisset, C. E., Barnard, K. E. & Booth, C. L. (1995). Toddler's language development: Sex differences within social risk. Developmental Psychology, 31, 851-865.
42. Nulman, I., Rovet, J. D., Altmann, D., Bradley, C., Einarson, T. & Koren, G. (1995). Neurodevelopment of adopted children exposed in utero to cocaine. Journal of Developmental and Behavioural Pediatrics, 16, 418-424.
43. O'Connor, M. J., Sigman, M. & Kasari, C. (1993). Interactive model for the association among maternal alcohol use, mother-infant interaction, and infant cognitive development. Infant Behavior and Development, 16, 177-192.
44. Olson, H. C. & Toth, S. K. (1999). Samples in research on prenatal cocaine exposure: Vexing problems and practical solutions. Journal of Drug Issues, 29, 237-252.
45. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L. & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the epidemiological catchment area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
46. Richardson, G. A., Hamel, S. C., Coldschmidt, L. & Day, N. L. (1999). Growth of infants prenatally exposed to cocaine/crack: Comparison of a prenatal care sample. Pediatrics, 104, no. 2.
47. Rutter, M. (1987). Psychosocial resilience and protective mechanisms. American Journal of Orthopsychiatry, 57, 316-331.
48. Rutter, M. (1995). Psychosocial adversity: Risk, resilience and recovery. Southern African Journal of Child and Adolescent Psychiatry, 7, 75-88
49. Rutter, M. (1998). Practitioner review: routes from research to clinical practice in child psychiatry: retrospect and prospect. Journal of Child Psychology and Psychiatry, 39, 805-816.
50. Sameroff, A. J. (2000). Ecological perspectives on developmental risk. In WAIMH handbook of infant mental health, Vol. 4, Infant mental health in groups at risk (pp. 1-33). New York: Wiley.
51. Singer, L. T. (1999). Advances and redirections in understanding effects of fetal drug exposure. Journal of Drug Issues, 29, 253-262.
52. Singer, L. T., Arendt, R., Song, L., Warshawski, E. & Kliegman, R. (1994). Direct and indirect interactions of cocaine with child-birth outcomes. Archives of Pediatrics and Adolescent Medicine, 148, 959-964.
53. Smith, L., Ulvund, S. E. & Lindemann, R. (1994). Very low birth weight infants ( < 1501 g) at double risk. Developmental and Behavioral Pediatrics, 15, 7-13.
54. Streissguth, A. (1997). Fetal alcohol syndrome, A guide for families and communities. Baltimore: Paul H. Brookes Publishing Co.
55. Tronick, E. Z. & Beeghly, M. (1999). Prenatal cocaine exposure, child development, and the compromising effects of cumulative risk. Clinics in Perinatology, 26, 151-171.
56. Weinberg, M. K. & Tronick, E. Z. (1992). Sex differences in emotional expression and affective regulation in 6-month-old infants. (Abstract.) Society for Pediatric Research, 31, 15A.
57. Zuckerman, B. & Brown, E. R. (1993). Maternal substance abuse and infant development. In C. H. Zeanah (Ed.), Handbook of infant mental health (pp. 143-158). New York: Guilford Press.